Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients

Abstract

Heterotopic ossification occurring after the use of commercially available bone morphogenetic proteins has not been widely reported. We describe four cases of heterotopic ossification in patients treated with either recombinant bone morphogenetic protein 2 or recombinant bone morphogenetic protein 7. We found that while some patients were asymptomatic, heterotopic ossification which had occurred around a joint often required operative excision with good results. ©2008 British Editorial Society of Bone and Joint Surgery.